Cell Biolabs specializes in developing a wide range of innovative assays and reagents aimed at advancing research in cell and molecular biology. Their product offerings include various cell-based assays that assess critical biological processes such as angiogenesis, cell adhesion, migration, and transformation. Additionally, they provide tools for stem cell research and tumor sensitivity assays, which are essential for understanding cancer biology. Their expertise extends to protein and DNA analysis, including CRISPR/Cas systems and protein tagging, enabling researchers to explore cellular mechanisms and signaling pathways effectively.

The company also focuses on metabolism research, offering assays that measure various metabolic processes, including lipid, carbohydrate, and drug metabolism. Their oxidative stress assays are designed to evaluate cellular responses to oxidative damage, while pathogen and toxin assays facilitate the detection of bacterial and viral infections. Cell Biolabs provides a comprehensive suite of products, including ELISA kits for specific biomolecules, recombinant viruses for gene delivery, and selection guides for optimizing experimental design. This extensive portfolio supports researchers in their quest for discovery and innovation in life sciences.

United States

Cell Biolabs, Inc. proudly develops and commercializes innovative technologies and tools for life science research. We are committed to providing the best products that facilitate discovery of the mechanisms underlying cell function and disease.

Our unique, cutting-edge products are currently used around the world in the research laboratories of universities, government institutes, biotechnology and pharmaceutical companies

Cell Biolabs

Company Details